Breast Cancer Prognosis Fayetteville NC

Two new studies have found that levels of the protein caveolin-1 found in stromal connective tissue near a breast cancer tumor can accurately predict a patient's prognosis and may provide a pathway to future treatments in Fayetteville.

Shirish Devasthali, MD
(910) 483-8586
PO Box 53095
Fayetteville, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Languages
Hindi, Other, Russian
Education
Medical School: First Moscow Sechenov Med Inst, Moscow, Russia
Graduation Year: 1980
Hospital
Hospital: Cape Fear Valley Med Center, Fayetteville, Nc
Group Practice: Blood & Cancer Clinic

Data Provided by:
Sajjad A Malick, MD
(910) 609-6910
PO Box 42935
Fayetteville, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Dow Med Coll, Univ Of Karachi, Karachi, Pakistan
Graduation Year: 1988
Hospital
Hospital: Cape Fear Valley Med Center, Fayetteville, Nc; Betsy Johnson Mem Hosp, Dunn, Nc
Group Practice: Hematology Oncology Assoc

Data Provided by:
John Hugh Bryan, MD
(910) 609-6690
PO Box 41208
Fayetteville, NC
Specialties
Oncology (Cancer), Radiation Oncology, Pediatrics
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1969
Hospital
Hospital: Cape Fear Valley Med Center, Fayetteville, Nc; Southeastern Reg Med Ctr, Lumberton, Nc
Group Practice: South East Radiation Oncology

Data Provided by:
Surajit Chaudhuri, MD
(910) 483-8361
1205 Cape Ct Ste B
Fayetteville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Nrs Med Coll, Univ Of Calcutta, Calcutta, West Bengal, India
Graduation Year: 1982

Data Provided by:
Istvan Pataki
(910) 609-6691
1638 Owen Dr
Fayetteville, NC
Specialty
Radiation Oncology

Data Provided by:
Herman Allen Godwin, MD
(919) 323-1152
1813 Lakeshore Dr
Fayetteville, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1963

Data Provided by:
Christina Lee Wells, MD
(910) 484-4615
1133 Offshore Dr
Fayetteville, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Va Sch Of Med, Charlottesville Va 22908
Graduation Year: 1992

Data Provided by:
Tariq Nazir, MD
(910) 483-8586
PO Box 53095
Fayetteville, NC
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Sind Med Coll, Univ Of Karachi, Karachi,
Graduation Year: 1990

Data Provided by:
Mykhanh Connie Nguyen, MD
(336) 716-4551
1638 Owen Dr
Fayetteville, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Univ Of Ca, Los Angeles, Ucla Sch Of Med, Los Angeles Ca 90024
Graduation Year: 1990

Data Provided by:
Kamal Manubhai Bakri, MD
(910) 609-6910
1638 Owen Dr
Fayetteville, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Med Coll, Baroda Univ, Baroda, Gujarat, India
Graduation Year: 1972
Hospital
Hospital: Cape Fear Valley Med Center, Fayetteville, Nc; Highsmith-Rainey Memorial Hosp, Fayetteville, Nc; Betsy Johnson Mem Hosp, Dunn, Nc
Group Practice: Hematology Oncology Assoc

Data Provided by:
Data Provided by:

Breast Cancer Prognosis

Provided By:

FRIDAY, May 22 (HealthDay News) -- Two new studies have found that levels of the protein caveolin-1 found in stromal connective tissue near a breast cancer tumor can accurately predict a patient's prognosis and may provide a pathway to future treatments.

Low levels of caveolin-1, which plays a role in how cells absorb things, in the stromal cells were linked to a poor patient outcome in a study by Dr. Agnieszka K. Witkiewicz, from Thomas Jefferson University in Philadelphia, and colleagues. The findings are published in the June issue of the American Journal of Pathology.

The second study, in the same issue of the journal, found that a similar lack of stromal caveolin-1 in mice was associated with more aggressive tumor growth in the rodents, according to Erica K. Sloan, from the Peter MacCallum Cancer Centre in East Melbourne, Australia, and colleagues.

The findings led Sloan's research team to hypothesize that caveolin-1 may work as a tumor suppressant, at least in stromal tissue.

"These studies suggest that stromal caveolin-1 expression may be a potential therapeutic target and a valuable prognostic indicator of breast cancer progression," Sloan and colleagues concluded in their report.

Previous research had found that caveolin-1 plays a big part in the development of breast cancer tumors, according to a news release from the journal.

More information

The American Cancer Society has more about breast cancer.

SOURCE: American Journal of Pathology, news release, May 22, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com